N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide

C22H20F5N5O — CID 130321879

IUPACN-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide
SMILESCc1cnn(-c2cc(C(=O)Nc3ccc(F)c(NC4NC[C@@H]4C)c3F)cc(C(F)(F)F)c2)c1
InChIInChI=1S/C22H20F5N5O/c1-11-8-29-32(10-11)15-6-13(5-14(7-15)22(25,26)27)21(33)30-17-4-3-16(23)19(18(17)24)31-20-12(2)9-28-20/h3-8,10,12,20,28,31H,9H2,1-2H3,(H,30,33)/t12-,20?/m0/s1
InChIKeyCTCNDNNJUPFIHD-SVZXGPMESA-N
MW465.43 g/mol
LogP4.71
Rot. Bonds5

About N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide

N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide (PubChem CID 130321879) has the molecular formula C22H20F5N5O and a molecular weight of 465.43 g/mol. Its IUPAC name is N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide.

Molecular Properties

Compound NameN-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide
PubChem CID130321879
Molecular FormulaC22H20F5N5O
Molecular Weight465.43 g/mol
Exact Mass465.16
IUPAC NameN-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide
SMILESCc1cnn(-c2cc(C(=O)Nc3ccc(F)c(NC4NC[C@@H]4C)c3F)cc(C(F)(F)F)c2)c1
InChIInChI=1S/C22H20F5N5O/c1-11-8-29-32(10-11)15-6-13(5-14(7-15)22(25,26)27)21(33)30-17-4-3-16(23)19(18(17)24)31-20-12(2)9-28-20/h3-8,10,12,20,28,31H,9H2,1-2H3,(H,30,33)/t12-,20?/m0/s1
InChIKeyCTCNDNNJUPFIHD-SVZXGPMESA-N
XLogP4.71
TPSA70.98 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms33
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500465.43
LogP ≤ 54.71
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide?
The IUPAC name of N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide (CID 130321879) is N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide.
What is the SMILES notation for N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide?
The canonical SMILES for N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide is Cc1cnn(-c2cc(C(=O)Nc3ccc(F)c(NC4NC[C@@H]4C)c3F)cc(C(F)(F)F)c2)c1.
What is the InChIKey of N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide?
The InChIKey is CTCNDNNJUPFIHD-SVZXGPMESA-N. The full InChI is InChI=1S/C22H20F5N5O/c1-11-8-29-32(10-11)15-6-13(5-14(7-15)22(25,26)27)21(33)30-17-4-3-16(23)19(18(17)24)31-20-12(2)9-28-20/h3-8,10,12,20,28,31H,9H2,1-2H3,(H,30,33)/t12-,20?/m0/s1.
What are the key properties of N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide?
N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide has a molecular weight of 465.43 g/mol, XLogP of 4.71, 5 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2,4-difluoro-3-[[(3S)-3-methylazetidin-2-yl]amino]phenyl]-3-(4-methylpyrazol-1-yl)-5-(trifluoromethyl)benzamide is sourced from PubChem (CID 130321879), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).